Track the Brainsway Ltd. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €607.2m. The latest transaction was disclosed on 22 June 2026 (Levée d'options). Among the most active insiders: Mitrany Rayten Michal Ety. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
7 ops.
Sell Volume
Fundamental score
Ranked 12,657 of 29,064 companies
55.3
score / 100
Value
32
Quality
79
FCF yld2.7%
Earn yld1.3%
EV/EBITDA53.7x
ROE13%
Gross mgn75%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Brainsway Ltd. es una empresa centrada en el desarrollo de tratamientos no invasivos para trastornos neurológicos utilizando estimulación magnética transcraneal. Cotiza en NASDAQ bajo el ticker BWAY.